News

Cardiac amyloidosis nuclear image. Image courtesy of the Department of Nuclear Medicine, Medical University of Vienna, Austria.The American Society of Nuclear…

Transthyretin amyloidosis (ATTR) is a systemic disease characterized by the deposition of misfolded transthyretin (TTR) fibrils. It most commonly presents as…

Elevated blood levels of phosphorylated tau (p-tau) are diagnostic of Alzheimer disease and are associated with the deposition of amyloid-β in the cerebral neuropil…

A certain blood protein regarded as an early indicator of Alzheimer's disease also appears to play a role in other disorders. Researchers at DZNE and the Hertie…

“It took almost three years to get a proper diagnosis,” said Scott, a retired firefighter and paramedic who has hereditary transthyretin amyloidosis (hATTR). It is…

The U.S. Food and Drug Administration (FDA) has lifted its hold on a large-scale clinical trial evaluating nexiguran ziclumeran, Intellia Therapeutics’ gene-editing…

ATTRACTnet was developed as an AI-based screening tool for transthyretin-mediated amyloid cardiomyopathy (ATTR-CM). In a real-world population, use of the…

Hereditary transthyretin‐mediated amyloidosis (hATTR) is a disorder that affects several body systems and can result in life‐threatening conditions like…

The US Food and Drug Administration (FDA) has released the clinical hold on a second trial evaluating Intellia Therapeutics’ transthyretin amyloidosis with…

CAMBRIDGE, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing…